ASIA Investing Board Member / Investment Committee for Longevity Venture Studio (global)

ASIA INVESTOR MEMBER OF INVESTMENT COMMITTEE

Maroon Research Institute is thrilled to share this exciting opportunity for active Investors in Healthy Aging & Longevity to be the ASIA Investing Board Member / Investor on the Investment Committee of its Longevity Venture Studio which will be launching globally in October 2025.

Don&apost miss this exceptional and unique opportunity to be an integral member of the Investment Committee for the 1st LONGEVITY VENTURE STUDIO GLOBALLY, supported by Family Offices, an expert R&D commercialization team, Artificial Intelligence operating partners, and some of the world&aposs leading institutions and strategic partners.

Virtual locations for IC members include the USA, UAE (incl. Dubai), KSA, Asia (incl. Hong Kong), and Europe. Studio has physical hubs in San Francisco, Houston, Boston, New York, London, Nairobi, Singapore.

APPLICATION DEADLINE 10 SEPT 2025

If you meet 100% of qualifications outlined below Welcome - please apply!

Short-listed applicants will be invited for interviews starting August 25

NB: This role is only relevant for investors potentially interested in investing in Venture Studio companies and not relevant for non-investors seeking advisory role only

UNIQUE ADVANTAGES for IC MEMBERS

• 1st GLOBAL LONGEVITY VENTURE STUDIO supported by expert R&D and commercialization team, AI operating partners, and some of the world&aposs leading institutions and strategic partners
• EQUITY in Studio ventures or investment vehicles subject to milestones
• Applicant Screening Committee member with input on venture selection
• Investment Committee member
• Access to quality global innovation pipeline in Healthy Aging, Longevity, Precision Medicine, Climate Impact on Health areas being supported and developed by the Institute
• Growth Equity Direct investments / co-investments opportunities without higher overhead costs or time allocation
• Build early relationship with potential investee companies
• Membership in MRI Community incl. access to thought leadership, investor roundtables, family office dinners, co-investor networking
• Opportunity to become key stakeholder in Venture Studio and MRI

.

QUALIFICATIONS

• Investment Commitment: $125k (US equiv.) over 2 years in Venture Studio, ventures, and/or investment vehicles
• Relevant Sector Expertise in Healthy Aging & Longevity, Precision Medicine, Preventative Health, Biotech, Marine BioTech, Built Environment-Health impacts, OR Artificial Intelligence
• Active Investor with strong interest in Studio innovation areas e.g. family office, angel, institutional, corporate / strategic investor
• Strong 10-year Investment Experience and Track Record / Deal Sheet in venture capital, growth equity, private equity
• Exceptional interpersonal, communication skills and experience within an entrepreneurial / innovation environment i.e. are you effective and fun to work with
• 2 Professional References available upon request - including 1 from an Investee company that you have exited
• Time Commitment: 3 hours / month
• BONUS: Investor who also brings a strategic partnership OR additional physical resources/hub to Studio

.

MAROON RESEARCH INSTITUTE (MRI)

Please follow MRI for updates!

LINKEDIN: https://www.linkedin.com/company/maroonresearchinstitute/

WEBSITE: https://www.maroon-institute.com/

Maroon Research Institute is a global non-profit corporation headquartered in Texas, USA, committed to advancing Healthy Aging & Longevity by tackling head on critical areas that have been under-innovated and under-funded by facilitating and accelerating critical innovation commercialization lifecycles and partnerships to solve material innovation gaps in proactive/personalized, Preventative Healthcare (Precision Medicine) for the early diagnosis, early detection, and reduction in chronic Population Health conditions, and direct negative Climate Impact on Health.

The Facts: Shockingly, only 9% of US Healthcare investment is invested in preventative & public health (worse only 3% in neurological & brain health globally and 6% in the U.S.!); this is despite the fact that US ranks 60th globally in life expectancy ... yet represents 64% of global pharma profits!

• Chronic conditions (incl. neurological & brain health, autoimmune conditions, respiratory, cardiovascular, certain high-risk cancers) impact 50% of the US population and drive 80% of healthcare costs.
• Only 2% of global Climate finance is invested in healthcare, despite environment being 1 of the greatest single determinants of Healthy Aging!

Global Partnerships & Infrastructure: This ground-breaking global Institute has expanding operations and infrastructure through its strategic partnerships and Hub network across the United States and globally. The Institute benefits from 501c3 US non-profit status through its administrator.

Complete R&D Innovation to Commercialization Lifecycle: The Institute advances innovation in Preventative Health with a priority on neurological, mental and brain health; autoimmune diseases; blood and cardiovascular health (including heart disease); inflammation; certain cancers; food and environmental allergies.

The Institute also promotes positive environmental and direct Climate Impact on Human Health through innovation in the Built Environment (materials innovation, carbon reduction), Blue Economy (marine biotech for Human Health, seaweed value chain, coastal and ocean regeneration), and leveraging Artificial Intelligence incl. Robotics to accelerate and deliver successful commercialization at scale.